N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD

ConclusionsThe new sequential algorithm reliably identifies liver inflammation and fibrosis in MAFLD, making it easier to exclude low-risk patients and recommending high-risk MAFLD patients for clinical trials and emerging pharmacotherapies.

http://link.springer.com/10.1007/s12072-022-10420-w

Source: Hepatology International - September 24, 2022 Category: Infectious Diseases Source Type: research